We also expanded our internal communication of pharmacovigilance-related matters and our internal PhV portal currently has almost users who join monthly discussions on patient safety and PhV. Our Corporate Safety Board (CSB) that includes our Chief Medical Officer and senior managers in our global patient safety and pharmacovigilance, regulatory affairs, medical affairs and legal departments continued its activities in 2014, meeting almost every month to review all aspects of safety and PhV performance.